About One bio
One bio is a company based in New York (United States) founded in 2015 by Matt Barnard and Matthew Amicucci. One bio has raised $27 million across 1 funding round from investors including iSelect, dsm-firmenich and Remy. One bio offers products and services including WholeFibers™. One bio operates in a competitive market with competitors including Pendulum, The Good Bug, Harmless Harvest, OptiBiotix Health and Probi, among others.
- Headquarter New York, United States
- Founders Matt Barnard, Matthew Amicucci
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$27 M (USD)
in 1 rounds
-
Latest Funding Round
$27 M (USD), Series A
Dec 12, 2024
-
Investors
iSelect
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of One bio
One bio offers a comprehensive portfolio of products and services, including WholeFibers™.
Integrates active plant fibers into food for gut health benefits.
Funding Insights of One bio
One bio has successfully raised a total of $27M through 1 strategic funding round. The most recent funding activity was a Series A round of $27 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in One bio
One bio has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include iSelect, dsm-firmenich and Remy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Series A and growth-stage investments are made by Alpha Edison.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in life sciences sector
|
Locked | Locked | Locked | |
|
E12 Ventures is focused on early-stage technology investments.
|
Locked | Locked | Locked |
Investor details for One bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by One bio
Investment portfolio details for One bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - One bio
Detailed financials for One bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
One Bio Comparisons
Peer comparison for One bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of One bio
One bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pendulum, The Good Bug, Harmless Harvest, OptiBiotix Health and Probi, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pendulum is focused on developing advanced probiotic solutions.
|
|
| Locked | Locked | Locked |
Synbiotic supplements and fermented products for gut health are provided.
|
|
| Locked | Locked | Locked |
Branded coconut water and probiotic beverages are manufactured and marketed.
|
|
| Locked | Locked | Locked |
Microbial strains are developed for treating human metabolic diseases.
|
|
| Locked | Locked | Locked |
Probiotic strains for health solutions are developed and manufactured.
|
Detailed competitors of One bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on One Bio
Complete news archive for One bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about One bio
One bio was founded in 2015 and raised its 1st funding round 9 years after it was founded.
One bio is headquartered in New York, United States. It is registered at New York, New York, United States.
Matt Barnard is the current CEO of One bio. They have also founded this company.
One bio is a funded company, having raised a total of $27M across 1 funding round to date.
one.bio was founded in 2015 in New York, United States, to support business partnering in the life sciences sector. Tools are offered for recruiting partners and screening opportunities, including the meet.bio platform, which connects companies, individuals, assets, and locations to facilitate interactions. The deals.bio tool is utilized for evaluating biotech and pharmaceutical prospects online. Operations focus on affordable, user-friendly solutions for professionals in this field.
One bio's top competitors include The Good Bug, Pendulum and OptiBiotix Health.
One bio offers WholeFibers™.
One bio has 9 investors. Key investors include iSelect, dsm-firmenich, Remy, Alpha Edison, and Leaps by Bayer.